Bristol-Myers Squibb to Take Part in Leerink Partners Inaugural Immuno-Oncology Roundtable Conference
Bristol-Myers Squibb will take part in Leerink Partners Immuno-Oncology Roundtable on October 1.
PRESS RELEASE
NEW YORK--(
Investors and the general public are invited to listen to a live webcast of the session at
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025